Authors:
Turcotte, JE
Debonnel, G
de Montigny, C
Hebert, C
Blier, P
Citation: Je. Turcotte et al., Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects, NEUROPSYCH, 24(5), 2001, pp. 511-521
Authors:
Robichaud, M
Beauchemin, V
Lavoie, N
Dennis, T
Debonnel, G
Citation: M. Robichaud et al., Effects of bilateral olfactory bulbectomy on N-methyl-D-aspartate receptorfunction: Autoradiographic and behavioral studies in the rat, SYNAPSE, 42(2), 2001, pp. 95-103
Citation: S. Couture et G. Debonnel, Some of the effects of the selective sigma ligand (+)pentazocine are mediated via a naloxone-sensitive receptor, SYNAPSE, 39(4), 2001, pp. 323-331
Citation: Je. Bermack et G. Debonnel, Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands, BR J PHARM, 134(3), 2001, pp. 691-699
Authors:
Beique, JC
Blier, P
de Montigny, C
Debonnel, G
Citation: Jc. Beique et al., Potentiation by (-)pindolol of the activation of postsynaptic 5-HT1A receptors induced by venlafaxine, NEUROPSYCH, 23(3), 2000, pp. 294-306
Authors:
Beique, JC
de Montigny, C
Blier, P
Debonnel, G
Citation: Jc. Beique et al., Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. In vivo electrophysiological studies in the rat, NEUROPHARM, 39(10), 2000, pp. 1800-1812
Authors:
Beique, JC
de Montigny, C
Blier, P
Debonnel, G
Citation: Jc. Beique et al., Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat, NEUROPHARM, 39(10), 2000, pp. 1813-1822
Authors:
Beique, JC
De Montigny, C
Blier, P
Debonnel, G
Citation: Jc. Beique et al., Venlafaxine: Discrepancy between in vivo 5-HT and NE reuptake blockade andaffinity for reuptake sites, SYNAPSE, 32(3), 1999, pp. 198-211
Authors:
de Montigny, C
Silverstone, PH
Debonnel, G
Blier, P
Bakish, D
Citation: C. De Montigny et al., Venlafaxine in treatment-resistant major depression: A Canadian multicenter, open-label trial, J CL PSYCH, 19(5), 1999, pp. 401-406
Citation: B. Gronier et G. Debonnel, Involvement of sigma receptors in the modulation of the glutamatergic/NMDAneurotransmission in the dopaminergic systems, EUR J PHARM, 368(2-3), 1999, pp. 183-196